plasminogen activator inhibitor PAI-1
Selected indexed studies
- A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? (Int J Mol Sci, 2021) [PMID:33800359]
- Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors. (Cancer Lett, 2023) [PMID:36889376]
- Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. (Front Biosci, 2007) [PMID:17485272]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? (2021) pubmed
- Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors. (2023) pubmed
- Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. (2007) pubmed
- Plasminogen activator inhibitor-1. (2004) pubmed
- A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence. (2024) pubmed
- Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. (2010) pubmed
- Plasminogen activator inhibitor-1 in cancer research. (2018) pubmed
- Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders. (2023) pubmed
- Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke. (2017) pubmed
- Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy. (2020) pubmed